免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Contour® 下一代血液葡萄糖監測系統

K 號:K193407 · 2021-12-23

決定日期2021-12-23
產品代碼NBW
諮詢委員會CH
決定相當於

器材摘要

Contour® next GEN Blood Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Ascensia Diabetes Care. It received FDA 510(k) clearance on 2021-12-23 under 510(k) number K193407. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

常見問題

What is the Contour® next GEN Blood Glucose Monitoring System?

Contour® next GEN Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2021-12-23. The listed applicant is Ascensia Diabetes Care. The 510(k) number is K193407.

When did Contour® next GEN Blood Glucose Monitoring System receive FDA 510(k) clearance?

Contour® next GEN Blood Glucose Monitoring System received FDA 510(k) clearance on 2021-12-23, under 510(k) number K193407.

Who is the listed applicant for Contour® next GEN Blood Glucose Monitoring System?

FDA 510(k) 記錄將 Ascensia Diabetes Care 列為申請人。這並不單獨確立設備製造商。

What is the FDA product code for Contour® next GEN Blood Glucose Monitoring System?

The FDA product code for Contour® next GEN Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Ascensia Diabetes Care 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:NBW)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑